These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 17826840)

  • 21. Friedreich Ataxia: From the Eye of a Molecular Biologist.
    Muthuswamy S; Agarwal S
    Neurologist; 2015 Sep; 20(3):51-5. PubMed ID: 26375377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long intronic GAA repeats causing Friedreich ataxia impede transcription elongation.
    Punga T; Bühler M
    EMBO Mol Med; 2010 Apr; 2(4):120-9. PubMed ID: 20373285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Missense mutations linked to friedreich ataxia have different but synergistic effects on mitochondrial frataxin isoforms.
    Li H; Gakh O; Smith DY; Ranatunga WK; Isaya G
    J Biol Chem; 2013 Feb; 288(6):4116-27. PubMed ID: 23269675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia.
    Sarsero JP; Li L; Wardan H; Sitte K; Williamson R; Ioannou PA
    J Gene Med; 2003 Jan; 5(1):72-81. PubMed ID: 12516053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA methylation in Friedreich ataxia silences expression of frataxin isoform E.
    Rodden LN; Gilliam KM; Lam C; Rojsajjakul T; Mesaros C; Dionisi C; Pook M; Pandolfo M; Lynch DR; Blair IA; Bidichandani SI
    Sci Rep; 2022 Mar; 12(1):5031. PubMed ID: 35322126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compound heterozygous FXN mutations and clinical outcome in friedreich ataxia.
    Galea CA; Huq A; Lockhart PJ; Tai G; Corben LA; Yiu EM; Gurrin LC; Lynch DR; Gelbard S; Durr A; Pousset F; Parkinson M; Labrum R; Giunti P; Perlman SL; Delatycki MB; Evans-Galea MV
    Ann Neurol; 2016 Mar; 79(3):485-95. PubMed ID: 26704351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3.
    Chan PK; Torres R; Yandim C; Law PP; Khadayate S; Mauri M; Grosan C; Chapman-Rothe N; Giunti P; Pook M; Festenstein R
    Hum Mol Genet; 2013 Jul; 22(13):2662-75. PubMed ID: 23474817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel deletion-insertion mutation identified in exon 3 of FXN in two siblings with a severe Friedreich ataxia phenotype.
    Evans-Galea MV; Corben LA; Hasell J; Galea CA; Fahey MC; du Sart D; Delatycki MB
    Neurogenetics; 2011 Nov; 12(4):307-13. PubMed ID: 21830088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Animal and cellular models of Friedreich ataxia.
    Perdomini M; Hick A; Puccio H; Pook MA
    J Neurochem; 2013 Aug; 126 Suppl 1():65-79. PubMed ID: 23859342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia.
    Rodríguez-Pascau L; Britti E; Calap-Quintana P; Dong YN; Vergara C; Delaspre F; Medina-Carbonero M; Tamarit J; Pallardó FV; Gonzalez-Cabo P; Ros J; Lynch DR; Martinell M; Pizcueta P
    Neurobiol Dis; 2021 Jan; 148():105162. PubMed ID: 33171227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicellular models of Friedreich ataxia.
    Puccio H
    J Neurol; 2009 Mar; 256 Suppl 1():18-24. PubMed ID: 19283346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.
    Al-Mahdawi S; Pinto RM; Ismail O; Varshney D; Lymperi S; Sandi C; Trabzuni D; Pook M
    Hum Mol Genet; 2008 Mar; 17(5):735-46. PubMed ID: 18045775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanded GAA repeats impede transcription elongation through the FXN gene and induce transcriptional silencing that is restricted to the FXN locus.
    Li Y; Lu Y; Polak U; Lin K; Shen J; Farmer J; Seyer L; Bhalla AD; Rozwadowska N; Lynch DR; Butler JS; Napierala M
    Hum Mol Genet; 2015 Dec; 24(24):6932-43. PubMed ID: 26401053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variations creating microRNA target sites in the FXN 3'-UTR affect frataxin expression in Friedreich ataxia.
    Bandiera S; Cartault F; Jannot AS; Hatem E; Girard M; Rifai L; Loiseau C; Munnich A; Lyonnet S; Henrion-Caude A
    PLoS One; 2013; 8(1):e54791. PubMed ID: 23382970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterising the neuropathology and neurobehavioural phenotype in Friedreich ataxia: a systematic review.
    Corben LA; Georgiou-Karistianis N; Bradshaw JL; Evans-Galea MV; Churchyard AJ; Delatycki MB
    Adv Exp Med Biol; 2012; 769():169-84. PubMed ID: 23560311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Friedreich's ataxia: past, present and future.
    Marmolino D
    Brain Res Rev; 2011 Jun; 67(1-2):311-30. PubMed ID: 21550666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A combined nucleic acid and protein analysis in Friedreich ataxia: implications for diagnosis, pathogenesis and clinical trial design.
    Saccà F; Puorro G; Antenora A; Marsili A; Denaro A; Piro R; Sorrentino P; Pane C; Tessa A; Brescia Morra V; Cocozza S; De Michele G; Santorelli FM; Filla A
    PLoS One; 2011 Mar; 6(3):e17627. PubMed ID: 21412413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SINEUP non-coding RNAs rescue defective frataxin expression and activity in a cellular model of Friedreich's Ataxia.
    Bon C; Luffarelli R; Russo R; Fortuni S; Pierattini B; Santulli C; Fimiani C; Persichetti F; Cotella D; Mallamaci A; Santoro C; Carninci P; Espinoza S; Testi R; Zucchelli S; Condò I; Gustincich S
    Nucleic Acids Res; 2019 Nov; 47(20):10728-10743. PubMed ID: 31584077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia.
    Perdomini M; Belbellaa B; Monassier L; Reutenauer L; Messaddeq N; Cartier N; Crystal RG; Aubourg P; Puccio H
    Nat Med; 2014 May; 20(5):542-7. PubMed ID: 24705334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapeutic strategies for Friedreich Ataxia: a review of the available data.
    Gunther K; Lynch DR
    Expert Opin Pharmacother; 2024 Apr; 25(5):529-539. PubMed ID: 38622054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.